{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:28:25Z","timestamp":1740144505182,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>For chronic congenital endocrine conditions, age at diagnosis is a key issue with implications for optimal management and psychological concerns. These conditions are associated with an increase in the risk of comorbid conditions, particularly as \u00a0it\u00a0concerns growth, pubertal development and fertility potential. Clinical presentation and severity depend on the disorder and the patient\u2019s age, but diagnosis is often late.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate age at diagnosis for the most frequent congenital endocrine diseases affecting growth and\/or development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and Methods<\/jats:title>\n                <jats:p>This observational cohort study included all patients (<jats:italic>n<\/jats:italic> = 4379) with well-defined chronic congenital endocrine diseases\u2014non-acquired isolated growth hormone deficiency (IGHD), isolated congenital hypogonadotropic hypogonadism (ICHH), ectopic neurohypophysis (NH), Turner syndrome (TS), McCune-Albright syndrome (MAS), complete androgen insensitivity syndrome (CAIS) and gonadal dysgenesis (GD)\u2014included in the database of a single multisite reference center for rare endocrine growth and developmental disorders, over a period of 14 years. Patients with congenital hypothyroidism and adrenal hyperplasia were excluded as they are generally identified during neonatal screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Median age at diagnosis depended on the disease: first year of life for GD, before the age of five years for ectopic NH and MAS, 8\u201310 years for IGHD, TS (11% diagnosed antenatally) and CAIS and 17.4 years for ICHH. One third of the patients were diagnosed before the age of five years. Diagnosis occurred in adulthood in 22% of cases for CAIS, 11.6% for TS, 8.8% for GD, 0.8% for ectopic NH, and 0.4% for IGHD. A male predominance (2\/3) was observed for IGHD, ectopic NH, ICHH and GD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The early recognition of growth\/developmental failure during childhood is essential, to reduce time-to-diagnosis and improve outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02099-3","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T12:02:37Z","timestamp":1636027357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Age at diagnosis in patients with chronic congenital endocrine conditions: a regional cohort study from a reference center for rare diseases"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4281-8252","authenticated-orcid":false,"given":"Wafa","family":"Kallali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Messiaen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roumaisah","family":"Sa\u00efdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soucounda","family":"Lessim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Viaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Dulon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Nedelcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinane","family":"Samara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Houang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Donadille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Courtillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GianPaolo","family":"de Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Carel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Christin-Maitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Netchine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"L\u00e9ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"2099_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1530\/EJE-18-0861","volume":"180","author":"SR Ali","year":"2019","unstructured":"Ali SR, Bryce J, Cools M, Korbonits M, Beun JG, Taruscio D, et al. The current landscape of European registries for rare endocrine conditions. Eur J Endocrinol. 2019;180:89\u201398.","journal-title":"Eur J Endocrinol."},{"key":"2099_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1210\/jc.2013-1891","volume":"99","author":"J L\u00e9ger","year":"2014","unstructured":"L\u00e9ger J, Olivieri A, Donaldson M, Torresani T, Krude H, van Vliet G, et al. European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. J Clin Endocrinol Metab. 2014;99:363\u201384.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","volume":"166","author":"B Coulm","year":"2012","unstructured":"Coulm B, Coste J, Tardy V, Ecosse E, Roussey M, Morel Y, et al. Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Arch Pediatr Adolesc Med. 2012;166:113\u201320.","journal-title":"Arch Pediatr Adolesc Med."},{"key":"2099_CR4","unstructured":"French_National_Plan.pdf [Internet]. [cited 1 Apr 2021]. Available from: https:\/\/www.orpha.net\/actor\/EuropaNews\/2006\/doc\/French_National_Plan.pdf"},{"issue":"Suppl 1","key":"2099_CR5","doi-asserted-by":"publisher","first-page":"O7","DOI":"10.1186\/1750-1172-9-S1-O7","volume":"9","author":"R Choquet","year":"2014","unstructured":"Choquet R, Landais P. The French national registry for rare diseases: an integrated model from care to epidemiology and research. Orphanet J Rare Dis. 2014;9(Suppl 1):O7.","journal-title":"Orphanet J Rare Dis."},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000324117","volume":"75","author":"MB Ranke","year":"2011","unstructured":"Ranke MB, Lindberg A, on behalf of the KIGS International Board. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review. Horm Res Paediatr. 2011;75:423\u201332.","journal-title":"Horm Res Paediatr."},{"key":"2099_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/jc.2018-01189","volume":"104","author":"CJ Child","year":"2019","unstructured":"Child CJ, Zimmermann AG, Chrousos GP, Cummings E, Deal CL, Hasegawa T, et al. Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program. J Clin Endocrinol Metab. 2019;104:379\u201389.","journal-title":"J Clin Endocrinol Metab."},{"issue":"7355","key":"2099_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/bmj.325.7355.70","volume":"325","author":"J-C Carel","year":"2002","unstructured":"Carel J-C. Adult height after long term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow up study of the French population-based registry. BMJ. 2002;325(7355):70\u201370.","journal-title":"BMJ."},{"key":"2099_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000082872","volume":"63","author":"F Darendeliler","year":"2005","unstructured":"Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, et al. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Horm Res Paediatr. 2005;63:40\u20137.","journal-title":"Horm Res Paediatr."},{"key":"2099_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000452887","volume":"87","author":"MB Ranke","year":"2017","unstructured":"Ranke MB, Lindberg A, Tanaka T, Camacho-H\u00fcbner C, Dunger DB, Geffner ME. Baseline characteristics and gender differences in prepubertal children treated with growth hormone in Europe, USA, and Japan: 25 years\u2019 KIGS\u00ae experience (1987\u20132012) and review. Horm Res Paediatr. 2017;87:30\u201341.","journal-title":"Horm Res Paediatr."},{"key":"2099_CR11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/js.2018-00390","volume":"3","author":"S Zborovski","year":"2019","unstructured":"Zborovski S, Palmert MR, Harrington J. Limited utility of biochemical screening for pituitary deficiencies and adverse effects in idiopathic GH deficiency. J Endocr Soc. 2019;3:1022\u201330.","journal-title":"J Endocr Soc."},{"key":"2099_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000089425","volume":"64","author":"M Tauber","year":"2005","unstructured":"Tauber M, Chevrel J, Diene G, Moulin P, Jouret B, Oliver I, et al. Long-term evolution of endocrine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome. Horm Res Paediatr. 2005;64:266\u201373.","journal-title":"Horm Res Paediatr."},{"key":"2099_CR13","doi-asserted-by":"crossref","unstructured":"Simon D, Hadjiathanasiou C, Garel C, Czernichow P, Leger J. Phenotypic variability in children with growth hormone deficiency associated with posterior pituitary ectopia. Clin Endocrinol (Oxf). 2006;0:060222010233011.","DOI":"10.1111\/j.1365-2265.2006.02484.x"},{"key":"2099_CR14","doi-asserted-by":"publisher","first-page":"e16367","DOI":"10.1371\/journal.pone.0016367","volume":"6","author":"G Gascoin-Lachambre","year":"2011","unstructured":"Gascoin-Lachambre G, Brauner R, Duche L, Chalumeau M. Pituitary stalk interruption syndrome: diagnostic delay and sensitivity of the auxological criteria of the Growth Hormone Research Society. PLoS ONE. 2011;6:e16367.","journal-title":"PLoS ONE"},{"key":"2099_CR15","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1371\/journal.pone.0142354","volume":"10","author":"C Bar","year":"2015","unstructured":"Bar C, Zadro C, Diene G, Oliver I, Pienkowski C, Jouret B, et al. Pituitary stalk interruption syndrome from infancy to adulthood: clinical, hormonal, and radiological assessment according to the initial presentation. PLoS ONE. 2015;10:2354.","journal-title":"PLoS ONE"},{"key":"2099_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1530\/EJE-10-0892","volume":"164","author":"R Reynaud","year":"2011","unstructured":"Reynaud R, Albarel F, Saveanu A, Kaffel N, Castinetti F, Lecomte P, et al. Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol. 2011;164:457\u201365.","journal-title":"Eur J Endocrinol."},{"key":"2099_CR17","doi-asserted-by":"publisher","first-page":"11099","DOI":"10.1038\/srep11099","volume":"5","author":"A Grimberg","year":"2015","unstructured":"Grimberg A, Huerta-Saenz L, Grundmeier R, Ramos MJ, Pati S, Cucchiara AJ, et al. Gender bias in US pediatric growth hormone treatment. Sci Rep. 2015;5:11099.","journal-title":"Sci Rep."},{"key":"2099_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/adc.2004.049817","volume":"90","author":"G Massa","year":"2005","unstructured":"Massa G. Trends in age at diagnosis of Turner syndrome. Arch Dis Child. 2005;90:267\u20138.","journal-title":"Arch Dis Child."},{"key":"2099_CR19","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm K, Juul S, Juel K, Naeraa RW, H\u00f8jbjerg Gravholt C. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91:3897\u2013902.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR20","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1210\/jc.2008-1049","volume":"93","author":"MJ Schoemaker","year":"2008","unstructured":"Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Mortality in women with Turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008;93:4735\u201342.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1530\/EJE-15-1000","volume":"174","author":"E Fiot","year":"2016","unstructured":"Fiot E, Zenaty D, Boizeau P, Haigner\u00e9 J, Dos Santos S, L\u00e9ger J, et al. X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndrome. Eur J Endocrinol. 2016;174:281\u20138.","journal-title":"Eur J Endocrinol."},{"key":"2099_CR22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/13697137.2017.1350841","volume":"20","author":"AJ Vincent","year":"2017","unstructured":"Vincent AJ, Nguyen HH, Ranasinha S, Vollenhoven B. Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic. Climacteric. 2017;20:442\u20137.","journal-title":"Climacteric."},{"key":"2099_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fendo.2018.00054","volume":"9","author":"J Woelfle","year":"2018","unstructured":"Woelfle J, Lindberg A, Aydin F, Ong KK, Camacho-Hubner C, Gohlke B. Secular trends on birth parameters, growth, and pubertal timing in girls with Turner syndrome. Front Endocrinol. 2018;9:54.","journal-title":"Front Endocrinol."},{"key":"2099_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13023-018-0976-2","volume":"14","author":"A Berglund","year":"2019","unstructured":"Berglund A, Viuff MH, Skakkeb\u00e6k A, Chang S, Stochholm K, Gravholt CH. Changes in the cohort composition of Turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study. Orphanet J Rare Dis. 2019;14:16.","journal-title":"Orphanet J Rare Dis."},{"key":"2099_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/ajmg.a.30092","volume":"129A","author":"N Baena","year":"2004","unstructured":"Baena N, De Vigan C, Cariati E, Clementi M, Stoll C, Caball\u00edn MR, et al. Turner syndrome: Evaluation of prenatal diagnosis in 19 European registries: prenatal diagnosis of Turner syndrome. Am J Med Genet A. 2004;129A:16\u201320.","journal-title":"Am J Med Genet A."},{"key":"2099_CR26","doi-asserted-by":"crossref","unstructured":"Viuff MH, Stochholm K, Uldbjerg N, Nielsen BB, the Danish Fetal Medicine Study Group, Gravholt CH. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome. Hum Reprod. 2015;30:2419\u201126.","DOI":"10.1093\/humrep\/dev192"},{"key":"2099_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000070220","volume":"59","author":"JE Ostberg","year":"2003","unstructured":"Ostberg JE, Conway GS. Adulthood in women with Turner syndrome. Horm Res Paediatr. 2003;59:211\u201321.","journal-title":"Horm Res Paediatr."},{"key":"2099_CR28","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1210\/jc.2005-0846","volume":"90","author":"J-C Carel","year":"2005","unstructured":"Carel J-C. Growth hormone in Turner syndrome: twenty years after, what can we tell our patients? J Clin Endocrinol Metab. 2005;90:3793\u20134.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR29","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","volume":"177","author":"CH Gravholt","year":"2017","unstructured":"Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:G1-70.","journal-title":"Eur J Endocrinol."},{"key":"2099_CR30","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/ajmg.a.61310","volume":"179","author":"AE Lin","year":"2019","unstructured":"Lin AE, Prakash SK, Andersen NH, Viuff MH, Levitsky LL, Rivera-Davila M, et al. Recognition and management of adults with Turner syndrome: From the transition of adolescence through the senior years. Am J Med Genet A. 2019;179:1987\u20132033.","journal-title":"Am J Med Genet A."},{"key":"2099_CR31","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1210\/jc.2018-00723","volume":"104","author":"P Scherdel","year":"2019","unstructured":"Scherdel P, Matczak S, L\u00e9ger J, Martinez-Vinson C, Goulet O, Brauner R, et al. Algorithms to define abnormal growth in children: external validation and head-to-head comparison. J Clin Endocrinol Metab. 2019;104:241\u20139.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jpeds.2019.09.023","volume":"216","author":"E Alexandrou","year":"2020","unstructured":"Alexandrou E, Cabrera-Salcedo C, Labilloy G, Tyzinski L, Smolarek TA, Andrew M, et al. Algorithm-driven electronic health record notification enhances the detection of Turner syndrome. J Pediatr. 2020;216:227\u201331.","journal-title":"J Pediatr."},{"key":"2099_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nrendo.2015.112","volume":"11","author":"U Boehm","year":"2015","unstructured":"Boehm U, Bouloux P-M, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, et al. European Consensus Statement on congenital hypogonadotropic hypogonadism\u2014pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547\u201364.","journal-title":"Nat Rev Endocrinol."},{"key":"2099_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1530\/EJE-17-0065","volume":"178","author":"M Bonomi","year":"2018","unstructured":"Bonomi M, Vezzoli V, Krausz C, Guizzardi F, Vezzani S, Simoni M, et al. Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH). Eur J Endocrinol. 2018;178:23\u201332.","journal-title":"Eur J Endocrinol."},{"key":"2099_CR35","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/j.juro.2008.06.045","volume":"180","author":"A Cheikhelard","year":"2008","unstructured":"Cheikhelard A, Morel Y, Thibaud E, Lortat-Jacob S, Jaubert F, Polak M, et al. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. J Urol. 2008;180:1496\u2013501.","journal-title":"J Urol."},{"key":"2099_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpsychores.2016.12.002","volume":"92","author":"BS Khorashad","year":"2017","unstructured":"Khorashad BS, Roshan GM, Reid AG, Aghili Z, Hiradfar M, Afkhamizadeh M, et al. Sexual orientation and medical history among Iranian people with complete androgen insensitivity syndrome and congenital adrenal hyperplasia. J Psychosom Res. 2017;92:55\u201362.","journal-title":"J Psychosom Res."},{"key":"2099_CR37","doi-asserted-by":"publisher","first-page":"E1540","DOI":"10.1210\/jc.2012-1388","volume":"97","author":"M Lindhardt Johansen","year":"2012","unstructured":"Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E, Kj\u00e6rgaard S, Petersen BL, Skakkeb\u00e6k NE, et al. 45, X\/46, XY Mosaicism: phenotypic characteristics, growth, and reproductive function\u2014a retrospective longitudinal study. J Clin Endocrinol Metab. 2012;97:E1540-9.","journal-title":"J Clin Endocrinol Metab."},{"key":"2099_CR38","first-page":"167","volume":"5","author":"M Cools","year":"2011","unstructured":"Cools M, Wolffenbuttel KP, Drop SLS, Oosterhuis JW, Looijenga LHJ. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev Genet Mol Biol Evol Endocrinol Embryol Pathol Sex Determ Differ. 2011;5:167\u201380.","journal-title":"Sex Dev Genet Mol Biol Evol Endocrinol Embryol Pathol Sex Determ Differ."},{"issue":"Suppl 3","key":"2099_CR39","first-page":"897","volume":"15","author":"N Albers","year":"2002","unstructured":"Albers N, J\u00f6rgens S, Deiss D, Hauffa BP. McCune-Albright syndrome\u2013the German experience. J Pediatr Endocrinol Metab JPEM. 2002;15(Suppl 3):897\u2013901.","journal-title":"J Pediatr Endocrinol Metab JPEM."},{"key":"2099_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13023-016-0496-x","volume":"11","author":"E-K Cho","year":"2016","unstructured":"Cho E-K, Kim J, Yang A, Ki C-S, Lee J-E, Cho SY, et al. Clinical and endocrine characteristics and genetic analysis of Korean children with McCune\u2013Albright syndrome: a retrospective cohort study. Orphanet J Rare Dis. 2016;11:113.","journal-title":"Orphanet J Rare Dis."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02099-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T12:12:49Z","timestamp":1636027969000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02099-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02099-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2021,11,4]]},"assertion":[{"value":"9 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Paris Nord Ethics Review Committee for Biomedical Research Projects (CEERB) (No. 12-029).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All the authors have approved the submitted version.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"469"}}